Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
AAPS PharmSciTech ; 18(8): 3140-3150, 2017 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-28534299

RESUMO

The purpose of this research was to design and characterize an immediate-release formulation of carbamazepine (CBZ), a poorly soluble anti-epileptic drug, using a porous silica carrier. Carbon dioxide in its supercritical state (2000 psi, 30-35°C) was used as an anti-solvent to precipitate CBZ onto two particle size variants of silica. Adsorption isotherms were used as a pre-formulation strategy to select optimum ratios of silica and CBZ. The obtained drug-silica formulations were characterized by dissolution studies, differential scanning calorimetry (DSC), powder X-ray diffraction (PXRD), and scanning electron microscopy (SEM). This formulation strategy resulted in a 2.4-fold improvement in dissolution rate when compared to pure drug after 30 min of dissolution testing. PXRD and DSC confirmed the amorphous nature of CBZ in the formulations as well as the differences in polymorphic forms of commercial and supercritical fluid-processed CBZ. Additionally, solid-state NMR spectroscopy showed that the spin-lattice relaxation time for bulk drug (without silica) was ∼7.5 times greater than that for silica-confined CBZ, implying that when CBZ was adsorbed onto mesoporous silica, it is structurally disordered and had higher structural mobility, a characteristic of amorphous solids. The mesoporous silica matrix prevented CBZ crystal growth by imposing spatial constraint on CBZ nuclei and hence resulted in faster dissolution compared to bulk solid drug. Adsorption onto mesoporous silica using supercritical fluid technology may be used as a novel formulation strategy for amorphization of poorly soluble compounds, in turn improving their dissolution rate.


Assuntos
Carbamazepina/química , Carbamazepina/metabolismo , Cromatografia com Fluido Supercrítico/métodos , Dióxido de Silício/química , Dióxido de Silício/metabolismo , Adsorção , Anticonvulsivantes/química , Anticonvulsivantes/metabolismo , Cristalização , Microscopia Eletrônica de Varredura/métodos , Tamanho da Partícula , Porosidade , Solubilidade , Solventes/química , Solventes/metabolismo , Difração de Raios X/métodos
2.
Drug Dev Ind Pharm ; 40(1): 74-9, 2014 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-23298323

RESUMO

OBJECTIVE: Efficacy of a formulation of a poorly soluble centrally acting drug was evaluated by measuring dopamine responses using in vivo brain microdialysis. METHODS: Co-crystals (1:1) of carbamazepine and nicotinamide (CBZ-NCT) were complexed with cyclodextrins (γ-CDs) using supercritical fluid processing. Phase solubility and intrinsic dissolution were studied. Pharmacodynamic studies were performed on rats divided into three groups getting either CBZ-NCT in CD (20 mg/kg CBZ), pure CBZ solution or vehicle. A guide cannula was implanted to attach the microdialysis probe. Dialysate samples were analyzed for dopamine levels, which were compared between groups. RESULTS: The optimized CBZ formulation (5% w/w in γ-CD) with solubility - 10 mg/mL showed stepwise increase in dopamine response (maximum 250% of baseline) compared to neat CBZ or vehicle (p < 0.05). The pharmacokinetics of the drug required 30 min to elicit CNS response, which peaked at about 1.5-2 h. CONCLUSION: Hence, brain microdialysis was successfully used to evaluate a dissolution rate enhancing formulation.


Assuntos
Carbamazepina/administração & dosagem , Microdiálise/métodos , Niacinamida/química , gama-Ciclodextrinas/química , Animais , Anticonvulsivantes/administração & dosagem , Anticonvulsivantes/química , Anticonvulsivantes/farmacocinética , Encéfalo/metabolismo , Carbamazepina/química , Carbamazepina/farmacocinética , Química Farmacêutica/métodos , Cristalização , Dopamina/metabolismo , Composição de Medicamentos/métodos , Masculino , Ratos , Ratos Sprague-Dawley , Solubilidade , Fatores de Tempo
3.
Crit Rev Ther Drug Carrier Syst ; 24(1): 41-61, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17430099

RESUMO

Cochleates are lipid-based supramolecular assemblies that display great potential as delivery systems for systemic delivery of drugs, including peptides, proteins, vaccines, oligonucleotides, and genes. This is mainly attributed to their high stability and biocompatibility and their ability to deliver both hydrophilic and lipophilic drugs. Cochleates have a unique multilayered spiral structure, which is composed of a negatively charged phospholipid and a divalent cation, and can encapsulate diverse drug molecules of various shapes and sizes while minimizing toxicity associated with polymeric materials present in micro- and nanoparticle systems. This review describes current technological advances in the preparation methods, physicochemical characterization, and potential applications of cochleates as a drug delivery system for systemic delivery of various types of therapeutic agents.


Assuntos
Cátions/química , Composição de Medicamentos , Sistemas de Liberação de Medicamentos , Fosfolipídeos/química , Administração Oral , Humanos , Injeções , Tecnologia Farmacêutica
4.
Expert Opin Drug Metab Toxicol ; 12(3): 281-9, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26799671

RESUMO

INTRODUCTION: Drug resistance is the major obstacle impeding the efficacy of chemotherapeutic agents. Although numerous drug delivery techniques have been developed to combat drug resistance, their limitations of non-specific targeting and inconsistent bioavailability has led to the search of novel delivering strategies, such as nanoparticles. AREAS COVERED: Nanoparticles for anti-cancer drug delivery are microscopic preparations encapsulating a chemotherapeutic and a chemosensitizer into a rationally designed drug delivery vehicle. Nano-strategies directed against multi-drug resistance (MDR) can be categorized into those inhibiting the drug efflux pumps, those effective against the cellular factors of drug resistance, and the combinational based strategies. Here, we review the most recent literature to reposition nanoparticles as chemotherapeutics and inhibitors of MDR. EXPERT OPINION: Novelty in anti-cancer drug delivery has led to the formulation of chemotherapeutics and MDR inhibitors as nano-preparations, which are multi-functional and have better tumor cell-targeting effects. Their characteristics of size and surface attachments make them readily diffusible through the tumor vasculature and increase their retention time as well. With a better understanding of the molecular mechanisms of drug resistance, more potent and multi-targeted nano-preparations can be formulated in the near future.


Assuntos
Antineoplásicos/administração & dosagem , Nanopartículas , Neoplasias/tratamento farmacológico , Animais , Antineoplásicos/farmacocinética , Antineoplásicos/farmacologia , Disponibilidade Biológica , Sistemas de Liberação de Medicamentos , Desenho de Fármacos , Resistência a Múltiplos Medicamentos , Resistencia a Medicamentos Antineoplásicos , Humanos , Neoplasias/patologia , Tamanho da Partícula
5.
Crit Rev Ther Drug Carrier Syst ; 20(2-3): 215-47, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-14584524

RESUMO

Improvement of oral bioavailability of poorly water-soluble drugs remains one of the most challenging aspects of drug development. Solid dispersions seem to be a viable technique for overcoming this problem. However, the practical applicability of these systems has remained limited because of difficulties in conventional methods of preparation, poor reproducibility of physicochemical properties, difficulties in dosage form development, and lack of feasibility for scale-up of manufacturing processes. This review addresses various aspects of solid dispersions and compiles some of the recent technology transfers from various fields such as the chemical, food, and polymer industries for the preparation of solid dispersions that can lead to highly efficient and controlled large-scale manufacturing. Some of the practical aspects to be considered for the preparation of solid dispersions, such as selection of carrier and methods of physicochemical characterization, along with an insight into the release mechanism of drugs are also discussed. Finally, an in-depth rationale for limited commercialization of solid dispersions and recent revival has been considered.


Assuntos
Sistemas de Liberação de Medicamentos/métodos , Preparações Farmacêuticas/administração & dosagem , Tecnologia Farmacêutica/métodos , Administração Oral , Sistemas de Liberação de Medicamentos/tendências , Preparações Farmacêuticas/química , Tecnologia Farmacêutica/tendências
6.
J Pharm Sci ; 93(12): 2985-93, 2004 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-15468328

RESUMO

In this study improvement in the bioavailability of carbamazepine (CBZ) prepared as solid dispersions by conventional solvent evaporation and supercritical fluid (SCF) processing methods was assessed, along with the elucidation of the mechanism of improved absorption. Solid dispersions of CBZ in polyethylene glycol (PEG) with either Gelucire 44/14 or vitamin E-TPGS (TPGS) were evaluated by intrinsic dissolution. Directional transport through Caco-2 cell monolayers was determined in the presence and absence of TPGS. Cell viability in presence of various concentrations of amphiphilic carriers was seen. In vivo oral bioavailability was determined in rats. The apparent intrinsic dissolution rates (IDR) of both conventional- and SCF-CBZ/PEG 8000/TPGS solid dispersions were increased by 13- and 10.6-fold, respectively, relative to neat CBZ. CBZ was not a substrate of P-glycoprotein. Higher CBZ permeability was seen in presence of 0.1% TPGS. Cell viability studies showed significant cytotoxicity only at or above 0.1% amphiphilic carrier. Supercritical treated formulation (without amphiphilic carrier) displayed oral bioavailability on par with those conventional solid dispersions augmented with amphiphilic carriers. An in vitro-in vivo correlation was seen between IDR and the AUC of the various CBZ solid dispersions. Bioavailability of CBZ was more a function of dissolution as opposed to membrane effects. Although bioavailability from SCF processed dispersions was better than conventionally processed counterparts (except for one formulation containing Gelucire 44/14), an interaction of processing method and inclusion of an amphiphilic carrier, rather by one factor alone contributed to optimal absorption, thus giving contradictory results for Gelucire 44/14 and TPGS formulations.


Assuntos
Preparações Farmacêuticas/administração & dosagem , Preparações Farmacêuticas/metabolismo , Animais , Disponibilidade Biológica , Células CACO-2 , Sobrevivência Celular/efeitos dos fármacos , Sobrevivência Celular/fisiologia , Química Farmacêutica , Relação Dose-Resposta a Droga , Humanos , Masculino , Permeabilidade/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley , Solubilidade/efeitos dos fármacos
7.
J Pharm Sci ; 91(9): 1948-57, 2002 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-12210042

RESUMO

Solid dispersions of carbamazepine (CBZ) were formulated by supercritical fluid processing (SCP) and conventional solvent evaporation in polyethylene glycol (PEG) 8000 with either Gelucire 44/14 or vitamin E TPGS NF (d-alpha-tocopheryl PEG 1000 succinate). Formulations were evaluated by dissolution, scanning electron microscopy, powder X-ray diffraction, and differential scanning calorimetry, and excipient cytotoxicity in Caco-2 cells by MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt] assay. CBZ release was enhanced from supercritical fluid-treated CBZ and the CBZ/PEG 8000 (1:5), CBZ/PEG 8000/TPGS or Gelucire 44/14 (1:4:1) solid dispersions. The radically altered morphologies of SCP samples seen by scanning electron microscopy suggested polymorphic change that was confirmed by the X-ray diffraction and differential scanning calorimetry. Disappearance of the characteristic CBZ melting peak indicated that CBZ was dissolved inside the carrier system. Polymorphic change of CBZ during SCP led to faster dissolution. Therefore, SCP provides advantages over solid dispersions prepared by conventional processes.


Assuntos
Anticonvulsivantes/química , Carbamazepina/química , Anticonvulsivantes/farmacologia , Células CACO-2 , Varredura Diferencial de Calorimetria , Carbamazepina/farmacologia , Dióxido de Carbono , Química Farmacêutica , Cromatografia Líquida de Alta Pressão , Cristalização , Portadores de Fármacos , Humanos , Microscopia Eletrônica de Varredura , Polietilenoglicóis/toxicidade , Solubilidade , Solventes , Água , Difração de Raios X
8.
J Pharm Pharm Sci ; 5(3): 234-44, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-12553892

RESUMO

PURPOSE: A microencapsulation method that preserves the activity of an acid labile protein was developed. METHODS: Solvent evaporation technique that employed ICH class 2 and 3 solvents methanol and acetone, respectively to dissolve pH-sensitive Eudragit polymers was investigated. Total protein released and lactase activities were measured using the USP method A for enteric cores and optimized with respect to process parameters. RESULTS: The percentage yields and entrapment efficiencies were directly proportional to solid content. The mean percentage yield and entrapment efficiency of selected sample was 84 +/- 0.9% and 88 +/- 0.7%, respectively. The residual specific activity of lactase in the selected sample was 89% +/- 0.8 with a net activity loss of 2 +/- 0.28% and 4 +/- 0.52% under ambient and stressed storage, respectively. Dibutyl sebacate levels, lower processing temperatures and lower processing speeds were influential in modulating enzyme activity. The most important formulation factor affecting lactase stability was Eudragit type, followed in decreasing order by processing temperature, processing speed, and solid percentage. CONCLUSIONS: Reliable control of lactase release was achieved by microencapsulating the enzyme with pH-sensitive Eudragit L and S enteric polymers using either acetone- or methanol-based solvent but lactase activity was preserved only in acetone-based formulations.


Assuntos
Ácidos/química , Química Farmacêutica/métodos , Composição de Medicamentos/métodos , Proteínas/química , Acetona/química , Estabilidade de Medicamentos , Metanol/química , Microscopia Eletrônica de Varredura/métodos , Ácidos Polimetacrílicos/química , Projetos de Pesquisa , Solubilidade , Solventes/química
9.
Drug Deliv ; 19(6): 298-306, 2012 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-22928708

RESUMO

CONTEXT: Delivery of drugs and dyes through intact blood-brain barrier (BBB) is extremely sought-after. A safe and reliable measurement of delivery efficacy in live animals is necessary. OBJECTIVE: To investigate the brain uptake of FITC-dextran MW 4000 (FD4) by CD71/OX-26 coated nanoparticles by microdialysis sampling and fluorescence/confocal microscopy. MATERIALS AND METHODS: Methoxy-poly(ethylene glycol)-poly(lactide) (Met-PEG-PLA) and maleimide-poly(ethylene glycol)-poly(lactide) (Mal-PEG-PLA) nanoparticles were prepared by nanoprecipitation. The surfaces of the prepared nanoparticles were embellished with CD-71/OX-26 antibodies for brain targeting. Male Sprague Dawley rats received 0.4 mg/kg FD4 and equivalent nanoparticulate formulation through lateral tail vein. Animals were euthanized 24 h postadministration, after which the tissues were harvested and analyzed for FD4 concentrations. Tissues were fixed with paraformaldehyde, cryotomed to 20 µm sections, and analyzed by Total Internal Reflection microscopy. RESULTS: Particle sizes of 200 ± 25 nm and zeta potentials of -18 ± 1 mV were obtained. FD4 concentrations, determined using in vivo brain microdialysis, were high on the first day (~360 ng/mL) compared to 60 ng/mL on the following 2 days. The nanoparticle treated animals showed significantly higher (p < 0.05) FD4 concentrations in the brain than pure-FD4 treated animals. Immunopegylated nanoparticles sustained and enhanced Central nervous system (CNS) concentration of hydrophilic dye for at least 3 days. CONCLUSION: Immunopegylated nanoparticles produce enhanced and sustained uptake of brain permeability marker FD4 relative to controls.


Assuntos
Dextranos/administração & dosagem , Portadores de Fármacos/química , Sistemas de Liberação de Medicamentos , Fluoresceína-5-Isotiocianato/análogos & derivados , Nanopartículas , Animais , Anticorpos Monoclonais/administração & dosagem , Anticorpos Monoclonais/imunologia , Antígenos CD/imunologia , Barreira Hematoencefálica/metabolismo , Encéfalo/metabolismo , Dextranos/química , Dextranos/farmacocinética , Fluoresceína-5-Isotiocianato/administração & dosagem , Fluoresceína-5-Isotiocianato/química , Fluoresceína-5-Isotiocianato/farmacocinética , Humanos , Masculino , Maleimidas/química , Microdiálise , Microscopia Confocal , Microscopia de Fluorescência , Tamanho da Partícula , Poliésteres/química , Polietilenoglicóis/química , Ratos , Receptores da Transferrina/imunologia , Reprodutibilidade dos Testes , Fatores de Tempo , Distribuição Tecidual
10.
Eur J Pharm Biopharm ; 74(3): 442-50, 2010 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-19941957

RESUMO

The objective of the study was to formulate sulpiride-loaded nanoparticles (NPs) that can improve bioretention and achieve dose reduction by passively targeting the drug near the site of action. Methoxy PEG-PLA and maleimide PEG-PLA were synthesized via ring opening polymerization of L-lactide and used to prepare pegylated nanoparticles (NPs) loaded with sulpiride by emulsification and solvent evaporation method. Thiolated cationized bovine serum albumin (CBSA) was conjugated through the maleimide function to the NPs. Rhodamine B and Alexa Fluor 488 were used as fluorescent markers for nanoparticle uptake studies. The nanoparticles were characterized for particle size, zeta potential and drug loading. Sprague Dawley rats were administered with each of CBSA-NPs, BSA-NPs and uncoated NPs (10mg/kg) via tail vein; plasma and urine concentrations were measured and tissue sections were observed under fluorescence microscope. Characterized particles (mean particle size 329+/-44 nm) indicated the conjugation of cationic albumin to NPs (zeta potential shift from -39 mV to -19 mV). Fluorescence showed a high accumulation of CBSA-NPs in brain compared to that of BSA-NPs and uncoated NPs supported by plasma and urine profile. The significant results proved that CBSA-NPs could be a promising brain drug delivery for sulpiride.


Assuntos
Encéfalo/efeitos dos fármacos , Portadores de Fármacos/química , Maleimidas/química , Nanopartículas/química , Poliésteres/química , Polietilenoglicóis/química , Sulpirida/administração & dosagem , Animais , Encéfalo/metabolismo , Bovinos , Composição de Medicamentos , Sistemas de Liberação de Medicamentos/métodos , Injeções Intravenosas , Masculino , Maleimidas/síntese química , Microscopia Eletrônica de Varredura , Tamanho da Partícula , Polietilenoglicóis/síntese química , Ratos , Ratos Sprague-Dawley , Soroalbumina Bovina/química , Sulpirida/sangue , Sulpirida/farmacocinética , Sulpirida/urina , Propriedades de Superfície , Distribuição Tecidual
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA